Navigation Links
Heska Announces Quarterly Dividend of $0.10 Per Share
Date:5/8/2012

LOVELAND, Colo., May 8, 2012 /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA), a provider of advanced veterinary diagnostic and other specialty veterinary products, today announced that its Board of Directors has declared a cash dividend of $0.10 per share to its stockholders.  The dividend payment will be distributed on July 10, 2012 to stockholders of record as of June 29, 2012.  The Company intends to pay a regular quarterly dividend of $0.10 per share to its stockholders for the foreseeable future at the discretion of the Board of Directors considering available cash, anticipated cash needs, overall financial condition, loan agreement restrictions, future prospects for earnings and cash flows, anticipated tax treatment as well as other relevant factors.

Dr. Robert Grieve, Heska's Chairman and CEO, commented, "We are making good progress against our profitability goals for 2012 and we are pleased to share those profits with our loyal shareholders. Thank you for your continued support."

About Heska
Heska Corporation (NASDAQ: HSKA) sells advanced veterinary diagnostic and other specialty veterinary products.  Heska's state-of-the-art offerings to its customers include diagnostic instruments and supplies as well as single use, point-of-care tests, pharmaceuticals and vaccines.  The Company's core focus is on the canine and feline markets where it strives to provide high value products and unparalleled customer support to veterinarians.  For further information on Heska and its products, visit the company's website at www.heska.com.

Forward-Looking Statements
This announcement contains forward-looking statements regarding Heska's future financial and operating results.  These statements are based on current expectations and are subject to a number of risks and uncertainties.  Investors should note that there is an inherent risk in using past results, including trends, to predict future outcomes.  In addition, factors that could affect the business and financial results of Heska generally include the following: uncertainties regarding Heska's ability to sustain or successfully implement a routine quarterly cash dividend; uncertainties related to Heska's ability to maintain a given level of profitability, or profitability at all; uncertainties regarding the future tax treatment of dividends and the perceived desirability of continuing to pay a dividend under various tax structures which may be implemented through government action or inaction; uncertainties related to the willingness of new investors to invest in or existing investors to hold Heska's stock based on dividend payments; competition; uncertainties regarding Heska's reliance on third parties to whom Heska has granted substantial marketing rights to certain of Heska's existing products and who may be large Heska customers; uncertainties regarding Heska's ability to successfully market and sell its products in an economically sustainable manner; risks related to Heska's reliance on third parties to develop certain of Heska's future products; uncertainties regarding Heska's ability to successfully commercialize new products; risks regarding Heska's reliance on third-party suppliers; and the risks set forth in Heska's filings and future filings with the Securities and Exchange Commission, including those set forth in Heska's Annual Report on Form 10-K for the year ended December 31, 2011.


'/>"/>
SOURCE Heska Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. The Patent Board Ranks Heskas Science Strength in Biotechnology Industry Top 50
2. Heska to Present at the 24th Annual ROTH Conference
3. Heska Announces Sixth Consecutive Profitable Quarter
4. Webcast Alert: Heska Announces Fourth Quarter and Year-End 2011 Earnings Conference Call Webcast
5. Heska to Present at the Sidoti & Company, LLC Semi-Annual New York Micro-Cap Conference
6. Heska Announces Exploration of New Technologies Through Strategic Collaboration with Entegrion, Inc.
7. Webcast Alert: Heska Announces Third Quarter 2011 Earnings Conference Call Webcast
8. The Patent Board, IP Tracking and Analysis Firm, Ranks Heskas Science Strength in Biotechnology Industry Top 50
9. Heska to Present at LD MICRO Invitational on September 22, 2011
10. American Animal Hospital Association and Heska Corporation Announce New Online Continuing Education Series
11. Heskas 2011 "Inspiration in Action" Contest Begins: Support the Veterinary Profession and Help Animals in Need
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... Feb. 11, 2016 Brain Cancer patients ... method at West Cancer Center . Optune™, ... to inhibit cancer cell replication causing death of cancer ... a decade to show a significant extension in overall ... patients. Currently, West Cancer Center is the only medical ...
(Date:2/11/2016)... , Feb. 11, 2016  AbbVie, a ... AbbVie Rheumatology Scholarship, designed to provide financial support ... as they pursue higher education goals. Fifteen scholars ... the 2016-2017 school year. The AbbVie Rheumatology Scholarship ... Haas , vice president, corporate social responsibility, brand ...
(Date:2/11/2016)... -- PLAD, Inc. (OTC Pink: PLAD) is pleased to announce that ... targets, are adding key personnel to their national sales ... States Patent and Trademark Office for the characters "P.L.A.D.".    ... PLAD, Inc.  In January, PLAD established their presence in ... two new customers, Cumberland Goodwill EMS and Meadville Ambulance, ...
Breaking Medicine Technology:
(Date:2/11/2016)... Kimberton, PA (PRWEB) , ... February 12, 2016 , ... ... Carolyn’s classes are a fun and exciting way to get fit and healthy. Located ... Training LLC announces dates for a class designed for horseback riders who want to ...
(Date:2/11/2016)... ... February 11, 2016 , ... Student-doctors ... Osteopathic Association’s (AOA) Match Program Tuesday, February 9, taking one of the final ... osteopathic graduate medical education positions across the country. Of the 103 student-doctors who ...
(Date:2/11/2016)... ... February 12, 2016 , ... The Journal of Pain Research has ... The SJR uses data taken from the Scopus database (Elsevier B.V.) and is a ... received by the journal over a three year period and also the importance of ...
(Date:2/11/2016)... ... February 11, 2016 , ... Hall Integrative Health and ... for their simultaneous grand openings in March. All seven practices are set to ... wondering, is reversing diabetes possible? According to this 2011 CNN article it is ...
(Date:2/11/2016)... ... February 11, 2016 , ... ... webinar, “Intel’s Direct-to-Employee Benefit Model: A Case Study for Plans and Purchasers.” Executives ... system that’s partnering with Intel on value-based health benefits program Connected Care, will ...
Breaking Medicine News(10 mins):